Pharmalot... Pharmalittle... Good Morning

Rise and shine, everyone, another busy day is on the way. Yes, the middle of the week is here and, as always, there is much to do. Of course, this can be a good thing, unless you planned to take the day off. If not, then it's time to get cracking. So grab a cup of something stimulating and dig in to the menu of tidbits below. Meanwhile, we hope your day is filled with accomplishments and do stay in touch by writing to ed@pharmalot.com We accept classified information... Roche And AstraZeneca To Share Early Trial Data (The Wall Street Journal) Astellas Signs $490M Pact With Cytokinetics (Pharma Times) Common Meds With Caffeine May Be Linked To Stroke (Reuters) Novo Nordisk Confronts Lantus Challenge With Tresiba Data (PM Live) India Applies Second Phase Of Price Controls (Economic Times) KKR Pays $1.3B For PRA International (Outsourcing Pharma) Allergan Faces Generic Competition For Restasis Eye Drug (MarketWatch) EDITOR'S NOTE: Please check this post for additional stories during the day Read more
Source: Pharmalot - Category: Pharma Commentators Authors: Source Type: blogs